Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

NCT00136084

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Children's Hospital of Michigan (Wayne State University) Detroit, Michigan, United States
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
View Trial Details
Completed

Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia

NCT00002925

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • University of California San Diego Cancer Center La Jolla, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • CCOP - Christiana Care Health Services Wilmington, Delaware, United States
  • Walter Reed Army Medical Center Washington D.C., District of Columbia, United States
View all 33 locations
View Trial Details
Completed

A Phase 2 Study With IPI-926 in Patients With Myelofibrosis

NCT01371617

Conditions
Bone Marrow Diseases, Fibrosis, Bone Marrow, Hematologic Diseases, +3 more
Locations
  • Arizona Mayo Clinic Scottsdale, Arizona, United States
  • Stanford University School of Medicine, Division of Hematology Palo Alto, California, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease

NCT00295971

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +21 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details

Related conditions